Last update 01 Nov 2024
Shanghai Yunying Medical Technology Co., Ltd.

Shanghai Yunying Medical Technology Co., Ltd.

Startups
|
Private Company|
2015|
Zhejiang Sheng, China
|
10-50
|

Overview

Basic Info

Introduction
Shanghai Yunying Medical Technology Co., Ltd. is committed to creating a new ecosystem for precise cancer diagnosis and treatment. It comprehensively utilizes cutting-edge biotechnologies such as genetic mutation detection, gene methylation detection, and gene editing and recombination to provide an all-round precision medicine solution for cancer, from early precise screening to targeted drug testing and integrated drug development for cancer treatment. Yunying Medical's individualized drug testing technology services cover multiple areas of tumor molecular testing, and its technical service network now covers more than 1,000 hospitals in five major regions of China. Yunying Medical always adheres to the business philosophy of "quality as the foundation, professionalism as the guarantee, and service as the basis," and is efficient, pragmatic, and enterprising, serving the majority of cancer patients with exquisite technical services.

Tags

Neoplasms
Otorhinolaryngologic Diseases
Nervous System Diseases
Oncolytic virus

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
Oncolytic virus5
Top 5 TargetCount
CD3 x CD86 x PD-11

Corporation Tree

Boost your research with our corporation tree data.
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 07 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
4
1
Phase 1 Clinical
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Recombinant oncolytic herpes simplex virus type 1(Shanghai Yunying Medical Technology)
( CD3 x CD86 x PD-1 )
Stomach Cancer
More
Phase 1 Clinical
R-4
Neoplasms
More
Preclinical
R-146
Neoplasms
More
Preclinical
R-149
Neoplasms
More
Preclinical
R-153
Neoplasms
More
Preclinical
Login to view more data

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free